Search results :

MTHPC

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: L01XD05

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1
Constipation Constipation very common x
Dysphagia Dysphagia very common x
Haemorrhage Haemorrhage very common x
Haemoglobin Haemorrhage very common x
Pain Pain very common x
Stomatitis necrotising Stomatitis necrotising very common x
Anaemia Anaemia common x
Blister Blister common x
Dermatitis bullous Blister common x
Dizziness Dizziness common x
Oedema Oedema common x
Body temperature increased Body temperature increased common x
Localised infection Localised infection common x
Nausea Nausea common x
Sunburn Sunburn common x
Photosensitivity reaction Sunburn common x
Photosensitivity reaction common x
Trismus Trismus common x
Erythema Erythema common x
Vomiting Vomiting common x
Burning sensation Burning sensation common x
Stomatitis Mouth ulceration common x
Stomatitis x
Mouth ulceration Mouth ulceration common x
Injection site reaction Injection site reaction common x
Skin necrosis Skin necrosis common x
Skin exfoliation Skin necrosis common x
Thermal burn Thermal burn common x
Obstructive airways disorder Airway obstruction NOS x
Bone disorder Bone disorder x
Infection Infection x
Facial pain Facial pain x
Fistula Fistula x
Gastrointestinal disorder Gastrointestinal disorder x
Headache Headache x
Mediastinal disorder Mediastinal disorder x
Necrosis Necrosis x
Nervous system disorder Nervous system disorder x
Pharyngitis Pharyngitis x
Angiopathy Angiopathy x
Tongue disorder Tongue oedema x
Tongue oedema Tongue oedema x
Injection site pain Injection site pain x
Skin disorder Unspecified disorder of skin and subcutaneous tissue x
Sepsis Sepsis x
Face oedema Face oedema x
Vascular rupture Vascular rupture x
Infestation Infestation NOS x
Local swelling Local swelling x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

temoporfin / temoporfin

Side effects:44
Source:EMA

Color scheme:

standardalternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label